Developmental regulation of GLUT-1 (Erytroid/HepG2) and GLUT-4 (Muscle/Fat) glucose transporter expression in rat heart, skeletal muscle, and brown adipose tissue by Santalucía Albi, Tomàs et al.
0013.7227/92/1302-0837$03.00/0 
Endocrinology 
Copyright 0 1992 by The Endocrine Society 
Vol. 130, No. 2 
Printed in U.S.A. 
Developmental Regulation of GLUT- 1 (Erythroid/Hep 
G2) and GLUT-4 (Muscle/Fat) Glucose Transporter 
Expression in Rat Heart, Skeletal Muscle, and Brown 
Adipose Tissue* 
T. SANTALUCIA, M. CAMPS, A. CASTELLG, P. MUNOZ, A. NUEL, X. TESTAR, 
M. PALACIN AND A. ZORZANO 
Departament de Bioquimica i Fisiologia, Facultat de Biologia, Universitat de Barcelona. 
08028 Barcelona, Spain 
ABSTRACT. The expression of GLUT-1 (erythroid/Hep G2) 
and GLUT-4 (muscle/fat) glucose transporters was assessed 
during development in rat heart, skeletal muscle, and brown 
adipose tissue. GLUT-4 protein expression was detectable in 
fetal heart by day 21 of pregnancy; it increased progressively 
after birth. attaining levels close to those of adults at day 15 
post natal.‘In contrast, GLUT-4 messenger RNA (mRNA)was 
already present in hearts from 17 day-old fetuses. GLUT-4 
mRNA stayed low during early postnatal life in heart and brown 
adipose tissue and only increased after day 10 post natal. The 
expression pattern for GLUT-4 protein in skeletal muscle during 
development was comparable to that observed in heart. In con- 
trast to heart and skeletal muscle, GLUT-4 protein in brown 
adipose tissue was detected in high levels (30% of adult) during 
late fetal life. 
During fetal life, GLUT-l presented a very high expression 
level in brown adipose tissue, heart, and skeletal muscle. Soon 
after birth, GLUT-1 protein diminished progressively, attaining 
adult levels at day 10 in heart and skeletal muscle. GLUT-1 
mRNA levels in heart followed a similar pattern to the GLUT- 
1 protein, being very high during fetal life and decreasing early 
in post natal life. GLUT-1 protein showed a complex pattern in 
brown adipose tissue: fetal levels were high, decreased after birth, 
and increased subsequently in post natal life, reaching a peak 
by day 9. 
Progesterone-induced postmaturity protected against the de- 
crease in GLUT-1 protein associated with post natal life in 
skeletal muscle and brown adipose tissue. However, GLUT-4 
induction was not blocked by postmaturity in any of the tissues 
subjected to study. 
These results indicate that: 1) during fetal and early post 
natal life, GLUT-1 is a predominant glucose transporter isotype 
expressed in heart, skeletal muscle, and brown adipose tissue; 2) 
during early post natal life there is a generalized GLUT-1 
repression; 3) during development, there is a close correlation 
between protein and mRNA levels for GLUT-l, and therefore 
regulation at a pretranslational level plays a major regulatory 
role; 4) the onset of GLUT-4 protein induction occurs between 
days 20-21 of fetal life; based on data obtained in rat heart and 
brown adipose tissue, there is a dissociation during development 
between mRNA and protein levels for GLUT-4, suggesting mod- 
ifications at translational or posttranslational steps; and 5) 
postmaturity blocks the decrease in GLUT-l expression but not 
the induction of GLUT-4. observed soon after birth. All these 
findings suggest that GLUT-1 repression and GLUT-4 induction 
are mediated by different mechanisms. (Endocrinology 130: 
837-846, 1992) 
G LUCOSE transport by facilitated diffusion is ex- (cDNAs) encoding these different species have been iso- pressed in virtually all mammalian cells. Recent lated (l-11), which have been named GLUT-l (eryth- 
studies have established that this process is mediated, in roid/Hep G2), GLUT-2 (liver), GLUT-3 (brain), GLUT- 
mammalian cells, by a family of related glucose transport 4 (muscle/fat), and GLUT-5 (small intestine). These 
proteins. So far, five different complementary DNAs proteins exhibit considerable homology in their primary 
sequences, but differ in their biochemical properties and 
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differences in absolute expression, both carriers play 
relevant roles in respect to the cell economy of glucose. 
Thus, under basal conditions, glucose transport is main- 
tained by the activity of GLUT-l transporters present 
in the plasma membrane. However, after stimulation 
with insulin, the GLUT-4 isotype becomes the major 
glucose transporter in this membrane (18). In this regard, 
insulin plays a complex role in the regulation of glucose 
transport, since on one hand, it causes a rapid translo- 
cation of GLUT-4 carriers in isolated adipocytes and, on 
the other hand, it seems to be required to maintain 
GLUT-4 transporter expression, so adipocytes from di- 
abetic or starved animals show a marked depletion of 
GLUT-4 transporters (19-22), concomitant with a sub- 
stantial decrease in the effect of insulin-stimulating glu- 
cose transport (23-26). 
Regarding the development of the effect of insulin on 
glucose uptake by insulin-sensitive tissues, it is known 
that during fetal life, tissues such as heart or diaphragm 
have a high rate of glucose use (27, 28), which is greater 
than in adult tissue. In addition, it has been reported 
that fetal heart responds to insulin-increasing glucose 
transport (27), and that the effect of insulin on glucose 
transport in the diaphragm increases markedly during 
post natal life (28), showing no correlation with the total 
size of intracellular glucose transporters, as assessed by 
cytochalasin B binding (28). However, there is a lack of 
information regarding the developmental regulation of 
glucose transporter expression in insulin-sensitive tis- 
sues. Therefore, in this report we have investigated the 
expression of GLUT-l and GLUT-4 in heart, skeletal 
muscle, and brown adipose tissue during development 
in the rat. Here, we describe the high expression of 
GLUT-l during fetal life and the post natal acquisition of 
GLUT-4. 
Materials and Methods 
Materials 
[‘251]Goat anti-mouse immunoglobulin G and [‘251]protein A 
were purchased from Amersham (Amersham, UK). Hybond N 
was from Amersham and random priming DNA labeling kit 
from Boehringer (Mannheim, Germany). Immobilon was ob- 
tained from Millipore (Bedford, MA). All electrophoresis re- 
agents and mol wt markers were obtained from Bio-Rad (Rich- 
mond, CA). y-Globulin and most commonly used chemicals 
were from Sigma (St. Louis, MO). 
Animals and tissue sampling 
Female Wistar rats (150-200 g) obtained from our own 
colony were mated, and gestation was timed from the appear- 
ance of spermatozoids in vaginal smears. The rats were fed 
with Purina laboratory chow ad libitum and housed in animal 
quarters maintained at 22 C with a 12-h light, 12-h dark cycle. 
At different gestational times (17-21 days), mothers were an- 
esthetized with sodium pentobarbital (5-7 mg/lOO g body wt). 
Fetuses were removed, and interscapular brown adipose tissue, 
heart, and skeletal muscle (hindlimbs) were rapidly collected 
and frozen in liquid nitrogen. When the post natal period was 
studied, pups remained with their mother after delivery and 
were anesthetized with sodium pentobarbital at different times 
before tissue sampling. 
Postmature fetuses were obtained on day 23 from pregnant 
rats treated daily with 7 mg progesterone (35 mg/ml ricine oil) 
from day 20 of pregnancy (29). Control pregnant rats received 
equal volumes of ricine oil, and their pups were studied 3 days 
later (day 1 post natal). 
Preparation of membrane fractions from tissues 
Tissues were homogenized in 10 vol ice-cold buffer contain- 
ing 25 mM HEPES, 250 mM sucrose, 4 mM EDTA, 1 trypsin 
inhibitor unit/ml aprotinin, 25 mM benzamidine, 0.2 mM phen- 
ylmethylsulfonylfluoride, 1 FM leupeptin, and 1 FM pepstatin, 
pH 7.4. Homogenates from brown adipose tissue and heart were 
centrifuged at 5,000 x g for 5 min at 4 C. The supernatant was 
then centrifuged at 150,000 x g for 2 h at 4 C to obtain the 
membrane fractions. The homogenates from skeletal muscle 
were centrifuged at 15,000 x g for 20 min at 4 C. The super- 
natants were adjusted to 0.8 M KCl, incubated at 4 C for 30 
min, and then centrifuged for 90 min at 200,000 x g at 4 C to 
obtain the membranes. The membrane pellets were resus- 
pended in homogenization buffer and repeatedly passed 
through a 25-gauge needle before storage at -20 C. Proteins 
were measured by the method of Bradford (30) using y-globulin 
as a standard. 
Electrophoresis and immunoblotting of membranes 
Sodium dodecyl sulfate (SDS)-polyacrylamide gel electro- 
phoresis was performed on membrane protein in accordance 
with the method of Laemmli (31). Proteins were transferred to 
Immobilon as previously reported (18) in buffer consisting of 
20% methanol, 200 mM glycine, 25 mM Tris, pH 8.3. After 
transfer, the filters were blocked with 5% nonfat dry milk, 
0.02% sodium azide in PBS for 1 h at 37 C and were incubated 
with antibodies. Transfer was confirmed by Coomassie blue 
staining of the gel after the electroblot. Antibody lF8 purified 
by protein A chromatography (kindly donated by Dr. Paul F. 
Pilch, Boston University, Boston, MA) was used at 5-10 pg/ml 
in 1% nonfat dry milk, 0.02% sodium azide in PBS for 1 h at 
37 C, to immunoblot GLUT-4. Detection of antibody-antigen 
complexes was effected with goat antimouse [‘Ylantibody and 
autoradiography. Rabbit Bb antiserum raised against the pu- 
rified human erythrocyte glucose transporter (a gift of Dr. 
Christin Carter-Su, University of Michigan, Ann Arbor, MI) 
was used directly at a 1:400 dilution and was incubated with 
transferred protein overnight at room temperature in 1% non- 
fat dry milk, 0.02% sodium azide in PBS. Detection of the 
immune complex with the rabbit antibody was accomplished 
using [‘251]protein A for 4 h at room temperature. The autora- 
diograms were quantified using scanning densitometry. Im- 
munoblots were performed under conditions where autoradi- 
ographic detection was in the linear response range. 
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RNA isolation and Northern blot analysis 
Total RNA from heart was extracted using the acid guani- 
dinium isothiocyanate/phenol/chloroform method as described 
by Chomczynski and Sacchi (32). All samples had a 260/280 
absorbance ratio over 1.7. 
After quantification, total RNA (15 rg) was denatured at 65 
C in the presence of formamide, formaldehyde, and ethidium 
bromide (33) to allow the visualization of RNA. RNA was 
separated on a 1.2% agarose/formaldehyde gel and blotted on 
Hybond N filters. The RNA in gels and in filters was visualized 
with ethidium bromide and photographed by UV transillumi- 
nation to ensure the integrity of RNA, to check the loading of 
equivalent amounts of total RNA, and to confirm proper trans- 
fer. RNA was transferred in 10 x standard saline citrate (SSC; 
0.15 M NaCl and 0.015 M sodium citrate, pH 7.0). 
Blots were initially prehybridized for 4 h at 45 C in 50% 
formamide, 5 x Denhardt’s (1 X Denhardt’s solution is 0.02% 
polyvinylpyrolidone, 0.02% Ficoll, 0.02% BSA), 0.5% SDS, 5 x 
SSPE (1 X SSPE is 0.15 M NaCl, 1 mM EDTA, and 10 mM 
NaH2P04, pH 7.4), and 0.5 mg denatured salmon sperm DNA. 
The blots were then hybridized to the corresponding probes for 
12 h at 42 C in 50% formamide, 5 x Denhardt’s, 0.05% SDS, 5 
x SSPE, 10% dextran sulfate, and 0.5 mg denatured salmon 
sperm DNA. The cDNA probe for GLUT-l is a 1346-base pair 
EcoRI fragment and the cDNA probe for GLUT-4 is a 2007- 
base pair Sal1 fragment. Both cDNA probes were obtained from 
Dr. Graeme I Bell (University of Chicago). The cDNA probes 
were labeled with [“‘Plcytidine triphosphate by random oligo- 
nucleotide priming. The probes were included at 1.5 x lo6 cpm/ 
ml. Filters were washed for 15 min in 2 x SSC at room 
temperature, and then twice in 0.4 x SSC, 0.1% SDS (first 
wash for 20 min and second wash for 30 min) at 55 C. The 
abundance of specific glucose transporter message was quanti- 
tated by scanning densitometry of autoradiograms as described 
above. 
Results 
Expression of mRNA and protein levels of GLUT-4 and 
GLUT-l glucose transporters in rat heart during 
development 
The expression of GLUT-l and GLUT-4 glucose 
transporters was initially assessed during development 
of rats in cardiac muscle. To that end, membrane frac- 
tions and total RNA were purified from hearts during 
development, and transporter protein and mRNA con- 
tent was determined. No significant differences were 
detected regarding the yield of membrane protein per 
gram of heart in 21-day fetuses (9.2 f 2.1 mg protein/g 
tissue), l-day neonates (12.3 + 1.9 mg protein/g tissue), 
lo-day neonates (10.2 + 2.4 mg protein/g tissue), X-day 
neonates (11.1 f 1.7 mg protein/g tissue), or adults (13.6 
+ 3.2 mg protein/g tissue). In contrast, a greater RNA 
yield was obtained in heart during fetal (3.2 f 0.4 mg/g 
tissue) or early neonatal life (2.5 f 0.2 mg/g tissue) 
compared to the adult state (1.2 + 0.1 mg/g tissue). 
GLUT-4 protein was assessed by Western blot using 
the specific monoclonal antibody lF8 (13). GLUT-4 pro- 
tein was barely detectable in heart membrane fractions 
at days 19 and 20 of fetal life (Fig. l), and a low expres- 
sion was detected by day 21 (Fig. 1). Expression of 
GLUT-4 at day 21 of fetal life represents 13% of adult 
values. GLUT-4 increased after birth, becoming progres- 
sively more abundant and attaining adult levels after day 
15 of post natal life (Fig. 1). No difference in GLUT-4 
electrophoretic migration was detected throughout de- 
velopment. 
The presence of GLUT-4 mRNA was determined by 
Northern blot using a human cDNA probe under high 
stringency conditions. Thus, Northern analysis of brain 
tissue, which does not express GLUT-4 (13), did not 
reveal any labeling (data not shown). GLUT-4 mRNA 
levels were already detectable but low at day 17 of fetal 
life (Fig. 1) compared to the adult state (8% of adult 
levels). mRNA levels remained relatively low during 
early neonatal life (20% of adult levels) (Fig. 1) and 
substantially increased after day 10 post natal (Fig. 1). 
At day 15 post natal, GLUT-4 mRNA levels were still 
markedly lower than in the adult heart in spite of the 
fact that no differences were detected at the level of 
GLUT-4 protein. As with GLUT-4 protein, no difference 
in electrophoretic migration of GLUT-4 mRNA was 
detected during development. 
GLUT-l protein was assessed by Western blot using 
polyclonal antibody Bb against human erythrocyte glu- 
cose transporter, which does not cross-react with GLUT- 
4 transporter (18). This antiserum recognizes, in West- 
ern blot, polypeptides other than GLUT-l, showing ap- 
parent mol wts greater than the glucose carrier. However, 
when GLUT-l is initially immunoprecipitated using a 
C-terminal-specific monoclonal antibody (34), only the 
immunoprecipitate shows, by Western blot using anti- 
serum Bb, the band corresponding to GLUT-l (data not 
shown). Therefore, this antiserum is useful to determine 
the expression of GLUT-l protein. The expression of 
GLUT-l glucose transporter protein was much greater 
in heart membrane extracts from days 19, 20, or 21 of 
fetal life (Fig. 2) compared to the adult group. In fact, 
GLUT-l levels expressed in heart during the adult state 
only accounted for 2% of levels found during fetal life. 
However, soon after birth GLUT-l protein initiated a 
rapid decrease, and GLUT-l levels were already low after 
6 days (22% of fetal levels) and 10 days (6% of fetal 
levels) of neonatal life (Fig. 2). Antibody Bb allows the 
detection of differences in electrophoretic mobility be- 
tween GLUT-l from rat brain and from cultured rat 
renal fibroblasts (data not shown). However, no differ- 
ence in GLUT-l electrophoretic migration was detected 
throughout development. 
GLUT-l mRNA levels in heart followed a similar 
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FIG. 1. Expression of GLUT-4 protein and mRNA in heart during 
development. Total RNA and membrane proteins were purified from 
pooled hearts obtained from rats (from day 19 of fetal life through 15 
post natal and adult rats). Two hundred micrograms of membrane 
proteins or 15 fig total RNA from the different experimental groups 
were applied on gels. After blotting, GLUT-4 protein (top panel) was 
detected by incubation with monoclonal antibody lF8. GLUT-4 mRNA 
(middle panel) was detected after hybridization with a 2007-base pair 
Sal1 fragment as a cDNA probe (see Materials and Methods). Autora- 
diographs were subjected to scanning densitometry. The results of two 
to five separate experiments are shown and expressed as a percentage 
of adult values (bottom panel). SEMS ranged between 5-21% of mean 
values. 
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FIG. 2. Expression of GLUT-l protein and mRNA in heart during 
development. Total RNA and membrane proteins were purified from 
pooled hearts obtained from rats (from day 19 of fetal life through 15 
post natal and adult rats). One hundred micrograms of membrane 
proteins or 15 rg total RNA from the different experimental groups 
were applied on gels. After blotting, GLUT-l protein (top panel) was 
detected by incubation with antibody Bb. GLUT-l mRNA (middle 
panel) was detected after hybridization with a 1346-base pair EcoRI 
fragment as a cDNA probe and as described in Materials and Methods. 
Autoradiographs were subjected to scanning densitometry. The results 
of one to two separate experiments are shown and expressed as a 
percentage of fetal (day 21) values (bottom panel). 
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pattern to the GLUT-l protein, being very high during 
fetal life and decreasing early post natal (Fig. 2). 
Expression of GLUT-4 and GLUT-l protein in skeletal 
muscle during development 
In an attempt to define the existence of a general 
pattern, we next investigated the expression throughout 
development of GLUT-4 and GLUT-l glucose trans- 
porters in skeletal muscle. To this end, membrane frac- 
tions were purified from hindlimb skeletal muscle. A low 
yield of membrane proteins was detected in 21-day fe- 
tuses (2.7 + 0.6 mg protein/g tissue), l-day neonates (2.4 
+ 0.3 mg protein/g tissue), and 5-day neonates (2.5 rt 0.4 
mg protein/g tissue) compared to adult levels (5.2 + 0.7 
mg protein/g tissue). Membrane protein yield increased 
progressively in lo-day neonates (3.8 + 0.5 mg protein/ 
g tissue) and 15-day neonates (4.1 -I- 0.8 mg protein/g 
tissue). 
In keeping with the observations in heart, GLUT-4 
protein was initially detected in skeletal muscle by day 
21 of fetal life (Fig. 3). Expression of GLUT-4 at day 21 
of fetal life was low and only accounted for 6% of adult 
values. In addition, GLUT-4 protein substantially in- 
creased soon after birth and attained adult levels at day 
15 of neonatal life (Fig. 3). No differences in electropho- 
retie migration pattern was detected between GLUT-4 
in preparations from adult and perinatal groups. 
GLUT-l protein also presented a very high expression 
level during fetal life in skeletal muscle (Fig. 3). Thus, 
GLUT-l levels expressed in skeletal muscle during the 
adult state only accounted for 3% of levels found during 
fetal life (day 20 or day 21). Also in keeping with the 
pattern found in heart, GLUT-l protein initiated a rapid 
decrease soon after birth, so GLUT-l levels were low at 
day 3 post natal (20% of fetal levels). Protein levels 
comparable with the adult state were found by day 10 of 
neonatal life (Fig. 3). 
Expression of GLUT-4 and GLUT-l protein in brown 
adipose tissue during development 
The developmental regulation of GLUT-4 and GLUT- 
1 glucose transporter expression was also investigated in 
brown adipose tissue, an insulin-sensitive tissue that 
plays a critical thermogenic role in the newborn. To that 
end, membrane fractions were purified from interscapu- ’ 
lar brown adipose tissue. No difference in the yield of 
membrane proteins was detected in 21-day fetuses (19.8 
f 3.7 mg protein/g tissue) and 5-day neonates (14.9 f 
1.8 mg protein/g tissue) compared to adult levels (16.6 + 
2.2 mg protein/g tissue). 
GLUT-4 protein was initially detected in brown adi- 
pose tissue by day 20 of fetal life (8% of adult levels) 
(Fig. 4), and expression of GLUT-4 by day 21 of fetal 
life accounted for 30% of adult values. Thus, GLUT-4 
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FIG. 3. Expression of GLUT-4 and GLUT-l protein in skeletal muscle 
during development. Membranes were obtained from pooled hindlimb 
muscle from rats. Identical amounts of membrane proteins from the 
different experimental groups were applied on 10% acrylamide gels 
(200 pg for GLUT-4 and 100 rg for GLUT-l). Protein from the gels 
was transferred to immobilon and immunoblotted with lF8 (GLUT-4, 
top panel) or with Bb antiserum (GLUT-l, middle panel). Autoradi- 
ographs were subjected to scanning densitometry, and the results of 
three to five separate observations are shown (bottom panel). Data on 
GLUT-l are expressed as a percentage of fetal (day 21) values, whereas 
data on GLUT-4 are expressed as a percentage of adult values. 
protein in brown adipose tissue during fetal life was 
detected at high levels compared to the adult state. This 
represents a substantial difference between brown adi- 
pose tissue and heart and skeletal muscle. In addition, 
GLUT-4 protein substantially increased soon after birth, 
attaining adult levels between days 5-6 post natally (Fig. 
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FIG. 4. Expression of GLUT-4 and GLUT-l protein in brown adipose 
tissue during development. Membranes were obtained from pooled 
interscapular brown adipose tissue from rats. Identical amounts of 
membrane proteins from the different experimental groups were ap- 
plied on 10% acrylamide gels (200 pg for GLUT-4 and 100 pg for 
GLUT-l). Protein from the gels was transferred to immobilon and 
immunoblotted with 1FS (GLUT-4, top panel) or with Bb antiserum 
(GLUT-l, middle panel). Autoradiographs were subjected to scanning 
densitometry, and the results of four to five separate observations are 
shown (bottom panel). Data on GLUT-l are expressed as a percentage 
of fetal (day 21) values, whereas data on GLUT-4 are expressed as a 
percentage of adult values. 
4). Thus, adult levels for GLUT-4 protein were reached 
earlier in brown adipose tissue than in heart and skeletal 
muscle (Figs. 1 and 3). GLUT-4 mRNA was detected at 
low levels during fetal life (5% of adult levels at day 19) 
and remained relatively low during early neonatal life 
(6% of adult levels at day 1 post natal). GLUT-4 mRNA 
levels were still markedly lower by days 6, 9, 13, and 15 
post natal compared to the adult brown adipose tissue 
(data not shown). At these times, no differences between 
neonatal and adult tissues had been detected at the level 
of GLUT-4 protein. 
GLUT-l protein was also highly expressed in brown 
adipose tissue during fetal life (Fig. 4), however, its 
developmental pattern was more complex than in heart 
or skeletal muscle. Thus, GLUT-l levels diminished soon 
after birth (Fig. 4). This was followed by a rapid recovery 
period which led to a high expression level during days 
8-15 post natal. Later on, GLUT-l protein content de- 
creased to adult control levels (Fig. 4). Adult levels 
accounted for 40% of fetal values. 
Effect of postmaturity on GLUT-l and GLUT-4 
expression in brown adipose tissue, heart, and skeletal 
muscle 
GLUT-4 and GLUT-l proteins show an inverse pat- 
tern of changes in insulin-sensitive tissues in the peri- 
natal period (Figs. l-4); thus, whereas GLUT-l rapidly 
decreases soon after birth, GLUT-4 increases during that 
time. To determine whether these effects are a conse- 
quence of environmental changes associated with deliv- 
ery, the effect of postmaturity was next investigated. To 
this end, pregnant rats were treated for 3 days with 
progesterone (from days 20-23), and GLUT-l and 
GLUT-4 protein content was assessed in brown adipose 
tissue, skeletal, and cardiac muscle (Fig. 5). 
The content of GLUT-l protein was greater in the 
postmature group than in the control group (l-day post 
natal) in skeletal muscle and brown adipose tissue (Fig. 
5). In skeletal muscle, GLUT-l protein levels from post- 
mature fetuses remained between levels detected in 21- 
day-old fetuses and l-day-old neonates (control group), 
indicating a partial protection by post maturity on 
GLUT-l repression associated with early neonatal life. 
GLUT-l protein in brown adipose tissue from the post- 
mature group was similar to the levels detected in 21- 
day normal fetuses (data not shown), evidence that post 
maturity totally prevented the decrease in GLUT-l as- 
sociated with early post natal life in brown adipose tissue. 
Regarding GLUT-4 expression, no differences in pro- 
tein content were detected in heart from control and 
postmature groups (Fig. 5). Furthermore, GLUT-4 pro- 
tein was increased in skeletal muscle and brown adipose 
tissue as a result of progesterone-induced postmaturity 
(Fig. 5). In conclusion, GLUT-4 induction was never 
blocked by post maturity. 
Discussion 
In this study we have demonstrated the existence of a 
high expression of GLUT-l glucose transporters in in- 
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FIG. 5. Effect of post maturity on the expression of GLUT-l and 
GLUT-4 protein in insulin-sensitive tissues. Postmature fetuses were 
obtained on day 23 from pregnant rats treated daily with 7 mg proges- 
terone (in ricine oil) from day 20 of pregnancy. Control rats received 
equal volumes of ricine oil and were studied 3 days later (day 1 post 
natal). Membranes were obtained from heart, hindlimb muscle, and 
interscapular brown adipose tissue from rats. Two hundred micrograms 
of membrane proteins from the different experimental groups were 
applied on gels. Protein from the gels was transferred to immobilon 
and immunoblotted with Bb antiserum to detect GLUT-l (top panel) 
or antibody lF8 to visualize GLUT-4 (bottom panel). Autoradiographs 
were also subjected to scanning densitometry. The autoradiograms 
presented are representative from three separate observations. 
sulin-sensitive tissues during fetal life in the virtual 
absence of GLUT-4 carriers. Thus, we have found that 
GLUT-l carriers in insulin-sensitive tissues are around 
30- to 50-fold more abundant during fetal life than in 
adulthood in heart and skeletal muscle. GLUT-3 mRNA 
levels were undetectable in heart tissue from 21-day-old 
fetuses and from neonates, under conditions in which 
expression was detected in some tissues from adult rats 
(Castello, A., M. Furrias, M. Camps, X. Testar, M. 
Palacin, and A. Zorzano, unpublished results). A corol- 
lary of all these findings is that during fetal life, glucose 
uptake in peripheral tissues must be performed by 
GLUT-l carriers. Bearing in mind the role of GLUT-l 
on basal glucose uptake in isolated rat adipocytes (la), 
the high expression of GLUT-l glucose transporters in 
peripheral tissues during fetal and early neonatal life 
explains the high rates of glucose uptake described in rat 
fetal heart (27) and in the incubated intact diaphragm 
during development (28). 
It also should be mentioned that insulin causes stim- 
ulation of glucose uptake in fetal rat heart (27) and in 
diaphragm during early post natal life (28), that is, under 
conditions in which GLUT-4 is either absent or only 
scarce. These observations suggest that GLUT-l is an 
insulin target during fetal life, which agrees with data 
obtained in several cell types (18, 35), but which is in 
contrast to data obtained in skeletal muscle from adult 
rats where insulin promotes translocation of GLUT-4 
but not of GLUT-l carriers (36). In any event, whether 
the effect of insulin during fetal life is related to carrier 
translocation as described in heart or skeletal muscle 
(37-39) or is a consequence of alterations in intrinsic 
activity of carriers remains to be determined. 
The high expression of GLUT-l during fetal life is 
common to heart, skeletal muscle, and brown adipose 
tissue, and all these tissues also undergo a decrease soon 
after birth which is protected, to a different extent, in 
postmature fetuses. Ontogenic studies performed in rat 
and rabbit brain also have shown that GLUT-l protein 
and mRNA expression is high in fetal life, decreasing 
after birth (40-42). Furthermore, high GLUT-l mRNA 
levels have been substantiated in rat lung, liver, and 
kidney during fetal life (40, 43) and they also rapidly 
diminish after birth. All these findings favor the exist- 
ence of a circulating factor responsible for the enhanced 
expression of GLUT-l during fetal life and which dis- 
appears rapidly after delivery but not in postmaturity. 
In fetal heart, the high expression of GLUT-l carriers 
is paralleled by high levels of GLUT-l mRNA, suggesting 
the activation of a pretranslational step during fetal life. 
Whether the enhanced mRNA abundance is due to an 
increased rate of gene transcription or to an increased 
mRNA stability has not yet been determined. 
Induction of GLUT-4 protein was detected by day 20 
in brown adipose tissue (8% of adult values), and it was 
substantial by day 21 of gestation in brown adipose tissue 
(30% of adult values), heart (13% of adult values), and 
skeletal muscle (6% of adult values). This induction 
occurred later than the onset of induction of mRNA 
levels which, at least in fetal heart, were already detect- 
able by day 17. After the onset of the expression in late 
pregnancy, all tissues investigated showed a progressive 
increase in GLUT-4 protein content, and this induction 
was not blocked by postmaturity. GLUT-4 protein levels 
increased up to adult values in all tissues investigated; 
however, adult levels were attained earlier in brown 
adipose tissue than in heart and skeletal muscle. 
Recent observations have reported the localization of 
GLUT-4 glucose transporters in transverse tubule mem- 
branes in human skeletal muscle (44); in this regard, it 
is significant that the triads appear in rat skeletal muscle 
in significant numbers only post natally (45, 46), which 
coincides with the appearance of substantial GLUT-4 
expression. Whether the expression of GLUT-4 and pro- 
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tein components of transverse tubules is regulated during 
development with an identical time-dependence and by 
common regulatory factors deserves further study. 
We have observed in rat heart and brown adipose 
tissue a dissociation between mRNA and protein regard- 
ing GLUT-4 expression during development. Thus, 
whereas GLUT-4 protein increases progressively during 
post natal life, attaining adult values at day 6 or day 10, 
mRNA levels remain rather stable. This dissociation also 
has been reported for hepatic P-Fl-ATPase in early post 
natal life (47), and it suggests the existence of GLUT-4 
regulation either at a translational level or to an in- 
creased stability of GLUT-4 protein during development. 
Based on our data, we propose two different phases in 
heart and brown adipose tissue during development: an 
initial phase characterized by modifications at a trans- 
lational or posttranslational step for GLUT-4, and a 
later phase in which GLUT-4 mRNA increases and the 
prior modifications return to levels present in adult state. 
The overall development pattern for GLUT-4 and 
GLUT-l in heart and skeletal muscle somewhat resem- 
bles the pattern previously described in 3T3 adipocytes 
with differentiation (48,49). Thus, when 3T3 fibroblasts 
differentiate, GLUT-l content decreases to some degree 
or remains unaltered, and GLUT-4 initiates its expres- 
sion, and this is concomitant with a decrease in basal 
glucose uptake and an enhanced effect of insulin on 
glucose transport (48, 49). However, ontogenic develop- 
ment of muscle and adipose tissue broadly differ in 
quantitative terms from differentiation of 3T3 cells. 
Thus, whereas differentiation of 3T3 cells leads to vari- 
able changes on GLUT-l expression-from 20-100% of 
levels found in fibroblasts (48, 49), rat adult tissues 
present GLUT-l expression which is only about 2-3% 
of fetal levels. Furthermore, whereas in isolated rat adi- 
pocytes GLUT-4 represents more than 90% of total 
glucose carriers (18), in 3T3-Ll adipocytes GLUT-l and 
GLUT-4 are present at a 3:l molar ratio (50). 
In the present study, we have reported the triggering 
of GLUT-4 induction and GLUT-l repression during 
perinatal life. These two events seem to differ in various 
aspects: 1) whereas the mechanisms for GLUT-l repres- 
sion seem to be at a pretranslational level, the onset of 
GLUT-4 induction is dependent on translational or post- 
translational activation; 2) the timing of the two events 
is different, the onset of GLUT-4 mRNA induction being 
earlier than the repression of GLUT-l; and 3) whereas 
GLUT-l repression is inhibited by post maturity, 
GLUT-4 protein induction is not blocked. All these 
findings strongly suggest that the two events are me- 
diated by different mechanisms. 
The nature of the signals involved in the onset of 
GLUT-4 expression and GLUT-l repression is unknown. 
Insulin might be involved in the regulation of glucose 
transporter expression during perinatal life. In this re- 
gard, it should be pointed out that circulating insulin 
rises to high concentrations over the last 3 days of 
gestation in the rat, decreasing to low levels during early 
post natal development (51-54) and there is a substantial 
expression of insulin receptors, displaying high affinity 
binding sites, in rat fetal skeletal muscle (55). Regarding 
neural activity, it has been reported that sympathetic 
innervation is functionally active in rat muscle and 
brown adipose tissue near term (56-58) and also might 
be proposed as a modulator of glucose carrier expression. 
At present, studies are being conducted to test the par- 
ticipation of insulin or neural activity on the develop- 
mental regulation of GLUT-l and GLUT-4 expression 
in insulin-sensitive tissues. 
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